Skip to main content
. 2019 Nov 20;10:2669. doi: 10.3389/fimmu.2019.02669

Figure 4.

Figure 4

(A) Seroprevalence (%) of ecto-PfMSP10 and PfMSP10 regions in different age groups; 6–10 years (n = 22), 11–16 years (n = 22), and 16–20 years (n = 22). All PfMSP10 regions were immunogenic in natural infections. (B) Kaplan–Meier plot of the probability of remaining free from clinical malaria during the 1-year follow-up in respect to antibodies against PfMSP10 R1. Individuals with high antibody levels, above population median (red), are compared to those with low levels (black) (p < 0.05).